UPDATE: DEFENDANT’S SUMMARY JUDGEMENT MOTION GRANTED – CASE DISMISSED ON DEC. 12, 2022
Welcome to the Allergan plc Securities Litigation Website.
The information contained on this web page is only a summary of information presented in more detail in the Notice of Pendency of Class Action (the “Notice”). Because this website is just a summary, you should review the Notice for additional details.
Pendency of Securities Class Action
This website provides information regarding a class action lawsuit now pending in the United States District Court for the Southern District of New York (“Court”) against Allergan plc (“Allergan”), Brenton L. Saunders, Maria Teresa Hilado, Matthew M. Walsh, Frances DeSena, Mark Marmur, Paul Bisaro, and William Meury (“Defendants”).
This Action has not been settled and continues to be litigated. There is no settlement or monetary recovery at this time.
Who is a Class Member?
All individuals and entities that purchased or otherwise acquired Allergan preferred stock or common stock between January 30, 2017 and December 19, 2018, inclusive (the “Class Period”), and who were damaged thereby (the “Class”).
Excluded from the Class are Defendants, as defined above; the officers, directors, and affiliates of Allergan, at all relevant times; Allergan’s employee retirement or benefit plan(s) and their participants or beneficiaries to the extent they purchased or acquired Allergan common stock through any such plan(s); any entity in which Defendants have or had controlling interest; immediate family members of any excluded person; and the legal representatives, heirs, successors, or assigns of any excluded person or entity.
Your Rights as a Class Member
If you are a Class Member, your rights are affected by this Action. You also have the right to exclude yourself from the Class in accordance with the directions set forth in the more detailed Notice.
| YOUR LEGAL RIGHTS AND OPTIONS | |
|---|---|
| Do Nothing and Remain in the Class | If you are a Class Member and choose to remain in the Class, you do not need to do anything at this time other than retain documentation reflecting your transactions in Allergan preferred or common stock.
By choosing to remain in the Class, you will be bound by all past, present, and future orders and judgments in the Action, whether favorable or unfavorable. If any money is awarded to the Class, either through a settlement with Defendants or a judgment of the Court, you may be eligible to receive a share of that award. However, if you remain a Class Member, you may not pursue a lawsuit on your own behalf with regard to any of the issues in this Action. |
| Request to be Excluded from the Class by JANUARY 9, 2023 | If you choose to be excluded from the Class, you will not be bound by any judgment in this Action, nor will you be eligible to share in any recovery that might be obtained in this Action.
If you choose to be excluded or, in other words, opt out of the Action, you may individually pursue any legal rights that you may have against any of the Defendants. Please note that if you exclude yourself from the Class in order to pursue your own action individually, you may be barred from pursuing certain claims, including federal securities law claims, due to the expiration of certain applicable statutes of repose and limitations. You may wish to consult with your own counsel before deciding to request exclusion from the Class. Requests to be excluded from the Class must be postmarked no later than JANUARY 9, 2023, in accordance with the instructions in the Notice. |